🇺🇸 FDA
Pipeline program

TTP054

TTP054-201

Phase 2 small_molecule completed

Quick answer

TTP054 for Type 2 Diabetes Mellitus is a Phase 2 program (small_molecule) at vTv Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
vTv Therapeutics
Indication
Type 2 Diabetes Mellitus
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials